Shackelford Pharma Inc. — Regulation A 1-A/A
Shackelford Pharma Inc. of VANCOUVER, A1 filed a Regulation A 1-A/A with the SEC on 2020-07-20. Aggregate offering: $10.0M (Tier 2). Industry: Other.
Offering
- Filed: 2020-07-20
- Form: 1-A/A
- Accession: 0001062993-20-003385
- Tier: Tier 2
- Total aggregate offering: $10.0M
- Issuer portion: $10.0M
- Price per security: $1.0000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Dale Matheson Carr-Hilton Labonte LLP
- Jurisdictions: 128 states/territories
Issuer
- CIK: 0001811112
- Organized in: A1
- Incorporated: 2018
- Address: PO Box 10026 Pacific Centre S., 25th Flr, VANCOUVER, A1, V7Y 1B3
- Phone: 1-888-377-4225
- Employees: 1 full-time
Financial snapshot (as filed)
- Total assets: $133K
- Cash & equivalents: $82K
- Total liabilities: $475K
- Stockholder equity: $-342K
People (2)
| Name | Role | Location |
|---|
| Daniel Nauth | Signer | Hackensack, NJ |
| Daniel D. Nauth | Signer | VANCOUVER, A1 |
Other Reg A filings by this issuer (13)
More